Therapeutic options for the management of pancreatic cancer.
about
Pancreatic Cancer from Molecular Pathways to Treatment OpinionPancreatic cancer from bench to bedside: molecular pathways and treatment optionsAdvances in cryoablation for pancreatic cancerViro-immune therapy: A new strategy for treatment of pancreatic cancerClinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic CancerLong Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signalingGenomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.Deregulation of MicroRNA-375 inhibits cancer proliferation migration and chemosensitivity in pancreatic cancer through the association of HOXB3.SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent PathwayCancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin.Nanoformulations for therapy of pancreatic and liver cancers.MRI quantification of pancreas motion as a function of patient setup for particle therapy -a preliminary study.Clinical Practice Guidelines for Cryosurgery of Pancreatic Cancer: A Consensus Statement From the China Cooperative Group of Cryosurgery on Pancreatic Cancer, International Society of Cryosurgery, and Asian Society of Cryosurgery.Commentary: CHIPping away pancreatic tumors?Chemoresistance in pancreatic cancer: Emerging conceptsPreclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer.Phage-derived protein-mediated targeted chemotherapy of pancreatic cancer.Berries and other natural products in the pancreatic cancer chemoprevention in human clinical trials.CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma.Photothermal Effects of Reduced Graphene Oxide on Pancreatic Cancer.Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC-1 cell apoptosis via activating the mROS-HtrA2/Omi pathwaysCordycepin induces apoptosis in human pancreatic cancer cells via the mitochondrial-mediated intrinsic pathway and suppresses tumor growth in vivo
P2860
Q26743482-78CC15D8-060E-4AAF-B5EB-CC7B8FBE9828Q26747524-4366C668-92BF-4ACC-B54E-03BD6FB242EFQ26774633-C1E7BFFD-0EC2-4365-8146-580A8EAD17CAQ26774641-2D145594-37C9-40AE-A999-1CDF487E8381Q26785691-2B887F38-A845-4F98-8267-26825F5D7C1CQ28088454-0682BAE2-63AA-4F03-8013-E6D66578B56FQ33710074-761032FD-4A66-4169-9245-94A31985D314Q33838679-D6199EB0-20E3-4EB7-8317-CAC78BE4E471Q36878620-1B163506-20B2-48EB-900C-63279B167F78Q36901972-10B5FDE3-36B6-484D-8DEF-657F2B8D6C69Q37395832-35130392-A9DB-4B62-919D-4EFB37E7A945Q38421269-F865D644-79F2-422D-9BF4-851D47260629Q38495105-5F0C85BB-058F-454E-A555-00E9A2D000AFQ38905702-C507EE15-1AD7-4D59-95E8-C699B0D7ABECQ41386937-297E3F82-8799-4E5E-81A7-3791F2A026F2Q41982260-FBBD5223-292D-45DF-B4C3-041B1A43E249Q42002078-2E6DFD28-B937-463F-B561-D602F97F8F80Q47147548-CB61BAC3-13BF-4E13-8BF8-33107BE5E8F8Q47408611-C9925A1F-5B17-4231-A986-EBABAE6906F7Q49415169-DD5A9FEE-D7D4-4580-88CB-729FD90B1117Q52886494-4E087C4E-8941-4F55-97CC-EEF076E03FEBQ55364733-236FE05E-47FB-47E1-A4EF-65F6A98997CBQ58120151-CD1EE151-5303-42FA-9412-B5BB974DBA8BQ58806304-CC038261-6BFD-47CF-A713-E4A98BC65A93
P2860
Therapeutic options for the management of pancreatic cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Therapeutic options for the management of pancreatic cancer.
@ast
Therapeutic options for the management of pancreatic cancer.
@en
Therapeutic options for the management of pancreatic cancer.
@nl
type
label
Therapeutic options for the management of pancreatic cancer.
@ast
Therapeutic options for the management of pancreatic cancer.
@en
Therapeutic options for the management of pancreatic cancer.
@nl
prefLabel
Therapeutic options for the management of pancreatic cancer.
@ast
Therapeutic options for the management of pancreatic cancer.
@en
Therapeutic options for the management of pancreatic cancer.
@nl
P2093
P2860
P1476
Therapeutic options for the management of pancreatic cancer.
@en
P2093
Azeem A Rehman
Christopher S Gondi
Maria L Rossi
P2860
P304
11142-11159
P356
10.3748/WJG.V20.I32.11142
P407
P577
2014-08-01T00:00:00Z